Susquehanna International Group, LLP Oyster Point Pharma, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$7.95 - $11.68 $685,735 - $1.01 Million	86,256 Added 388.77%	108,443 $1.21 Million
Q3 2022 Nov 14, 2022	SELL	$4.41 - $8.38 $155,086 - $294,699	-35,167 Reduced 61.32%	22,187 $125,000
Q2 2022 Aug 15, 2022	BUY	$3.6 - $11.2 $206,474 - $642,364	57,354 New	57,354 $248,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $240,420 - $494,570	-28,021 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $284,973 - $531,278	28,021 New	28,021 $512,000
Q3 2021 Nov 15, 2021	SELL	$11.67 - $18.07 $121,928 - $188,795	-10,448 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$16.25 - $21.51 $169,780 - $224,736	10,448 New	10,448 $180,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.